Voloridge Investment Management Portfolio holdings
AUM
$27.1B
1-Year Return
25.54%
This Quarter Return
+8.86%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$27.5B
AUM Growth
+$573M
(+2.1%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
8.92%
Holding
1,408
New
226
Increased
421
Reduced
486
Closed
275
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$401M |
| 2 |
Mercado Libre
MELI
|
+$115M |
| 3 |
Chevron
CVX
|
+$112M |
| 4 |
Edwards Lifesciences
EW
|
+$109M |
| 5 |
Lam Research
LRCX
|
+$99M |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$187M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Gilead Sciences
GILD
|
+$163M |
| 4 |
Netflix
NFLX
|
+$156M |
| 5 |
NVIDIA
NVDA
|
+$137M |
Sector Composition
| 1 | Technology | 16.6% |
| 2 | Financials | 15.15% |
| 3 | Industrials | 14.92% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Healthcare | 13.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Photronics
PLAB
$1.36B
| $758K | ﹤0.01% |
+30,597
| New | +$758K |
|
1052
WesBanco
WSBC
$3.08B
| $744K | ﹤0.01% |
24,967
+668
| +3% | +$19.9K |
|
1053
Cytek Biosciences
CTKB
$522M
| $729K | ﹤0.01% |
131,578
-125,949
| -49% | -$698K |
|
1054
Plexus
PLXS
$3.72B
| $728K | ﹤0.01% |
5,324
-31,367
| -85% | -$4.29M |
|
1055
Healthcare Services Group
HCSG
$1.15B
| $727K | ﹤0.01% |
65,099
-42,358
| -39% | -$473K |
|
1056
Park National Corp
PRK
$2.75B
| $727K | ﹤0.01% |
4,325
-14,323
| -77% | -$2.41M |
|
1057
Fiverr
FVRR
$874M
| $715K | ﹤0.01% |
27,627
-23,663
| -46% | -$612K |
|
|
AAMI
1058
Acadian Asset Management Inc.
AAMI
$1.61B
| $706K | ﹤0.01% |
+27,814
| New | +$706K |
|
1059
Cytokinetics
CYTK
$6.16B
| $692K | ﹤0.01% |
13,101
-542,009
| -98% | -$28.6M |
|
1060
Quanex
NX
$743M
| $682K | ﹤0.01% |
24,576
-22,564
| -48% | -$626K |
|
1061
Avanos Medical
AVNS
$573M
| $672K | ﹤0.01% |
27,984
-20,161
| -42% | -$484K |
|
1062
Five Below
FIVE
$8.34B
| $670K | ﹤0.01% |
+7,587
| New | +$670K |
|
1063
Thomson Reuters
TRI
$79.2B
| $652K | ﹤0.01% |
+3,820
| New | +$652K |
|
1064
Rush Enterprises Class A
RUSHA
$4.52B
| $643K | ﹤0.01% |
+12,165
| New | +$643K |
|
1065
HEICO Class A
HEI.A
$34.8B
| $630K | ﹤0.01% |
+3,093
| New | +$630K |
|
|
SAFE
1066
Safehold
SAFE
$1.18B
| $622K | ﹤0.01% |
23,728
-19,163
| -45% | -$503K |
|
1067
Indivior
INDV
$3.08B
| $619K | ﹤0.01% |
+63,521
| New | +$619K |
|
1068
Gannett
GCI
$610M
| $605K | ﹤0.01% |
+107,660
| New | +$605K |
|
1069
89bio
ETNB
$1.27B
| $599K | ﹤0.01% |
+80,904
| New | +$599K |
|
1070
Collegium Pharmaceutical
COLL
$1.19B
| $585K | ﹤0.01% |
+15,131
| New | +$585K |
|
1071
DNOW Inc
DNOW
$1.66B
| $585K | ﹤0.01% |
45,206
-37,237
| -45% | -$481K |
|
1072
Celsius Holdings
CELH
$14.4B
| $570K | ﹤0.01% |
+18,178
| New | +$570K |
|
1073
California Water Service
CWT
$2.76B
| $559K | ﹤0.01% |
10,302
-91,455
| -90% | -$4.96M |
|
1074
Kforce
KFRC
$577M
| $556K | ﹤0.01% |
+9,044
| New | +$556K |
|
|
LADR
1075
Ladder Capital
LADR
$1.5B
| $538K | ﹤0.01% |
+46,344
| New | +$538K |
|